BeOne Medicines
ONC
#642
Rank
ยฃ28.02 B
Marketcap
ยฃ253.27
Share price
0.40%
Change (1 day)
40.96%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): ยฃ0.39

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is ยฃ0.48. In 2024 the company made an earnings per share (EPS) of -ยฃ4.56.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ0.39-108.63%
2024-ยฃ4.56
2022-ยฃ14.2628.21%
2021-ยฃ11.12-19.96%
2020-ยฃ13.8920.81%
2019-ยฃ11.5031.52%
2018-ยฃ8.74417.57%
2017-ยฃ1.69-37.16%
2016-ยฃ2.69158.95%
2015-ยฃ1.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-ยฃ0.18-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ0.69-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA